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A B S T R A C T   
Recent technological advancements in the field of chromatin biology have rewritten the textbook on nuclear 
organization. We now appreciate that the folding of chromatin in the three-dimensional space (i.e. its 3D “ar-
chitecture”) is non-random, hierarchical, and highly complex. While 3D chromatin structure is partially encoded 
in the primary sequence and thereby broadly conserved across cell types and states, a substantial portion of the 
genome seems to be dynamic during development or in disease. Moreover, there is growing evidence that at least 
some of the 3D structure of chromatin is functionally linked to gene regulation, both being modulated by and 
impacting on multiple nuclear processes (including DNA replication, transcription, and RNA splicing). In recent 
years, these new concepts have nourished several investigations about the functional role of 3D chromatin to-
pology dynamics in the heart during development and disease. This review aims to provide a comprehensive 
overview of our current understanding in this field, and to discuss how this knowledge can inform further 
research as well as clinical practice.   
1. Introduction 
Chromatin dynamics in the heart have fascinated cardiac biologists 
and pathologists for decades. More than 50 years ago it became apparent 
that not only gene expression but also nuclear shape, size, and chro-
matin density experience remarkable changes during postnatal car-
diomyocyte development [1,2]. Cardiomyocyte hypertrophy was also 
shown to modulate nuclear structure by inducing fetal-like nuclear 
features [1], mirroring the well-known reactivation of the fetal gene 
program. Moreover, hypoxia was reported to reversibly increase chro-
matin condensation [3,4], suggesting that nuclear organization can be 
highly dynamic. However, for many years such early morphological 
observations could not be translated into molecular-level details due to 
the lack of high-throughput methods to measure the dynamics of indi-
vidual loci. Thus, the potential link between changes in nuclear orga-
nization and heart development and disease remained largely 
speculative. 
Meanwhile, classical gene mapping and subsequent large-scale 
exome and genome sequencing studies provided ample evidence that 
alterations of nuclear function can cause both developmental defects 
and heart disease in adults. On the one hand, rare mutations in core 
cardiac transcription factors (TFs), such as NKX2-5 [5], TBX5 [6,7], and 
GATA4 [8,9], cause Mendelian congenital heart disease (CHD). More-
over, mutations in chromatin modifiers contribute to ~30% of all CHD 
cases associated to single nucleotide variants appearing for the first time 
in a family member (de novo), and to ~3% of all CHD cases [10–13]. On 
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the other hand, ~10% of dilated cardiomyopathy (DCM) cases are 
directly attributable to de novo or inherited mutations of just two genes 
involved in nuclear regulation of gene expression, LMNA (encoding 
nuclear intermediate filaments) and RBM20 (encoding a muscle-specific 
splicing factor), both of which lead to particularly malignant and 
aggressive disease [14–17]. These and other observations prompted a 
plethora of studies on the mechanisms involved in chromatin regulation 
in cardiac development and disease. However, until recently most such 
studies had focused on the so-called “nucleosomal scale”, which spans 
from a single DNA base pair (bp; which can be modified by dynamic 5’- 
cytosine-phosphate-guanine-3’ [CpG] methylation), to ~150 bp (the 
size of an individual nucleosome that can be modulated by post- 
transcriptional modifications of histone tails), to a few kilobases (kb; 
the range of action of nucleosome remodelers and other local-acting 
chromatin regulators). In this context, the role of “supra-nucleosomal” 
(i.e. up to megabase-sized, or chromosome-level) and “nuclear” scale (i. 
e. up to gigabase-sized, or genome-level) chromatin organization had 
remained largely unknown. 
Over the last decade, the development of powerful technologies to 
map three dimensional (3D) chromatin folding (i.e. its “architecture”), 
particularly proximity ligation-based chromosome conformation cap-
ture (3C) technologies (Fig. 1 and Glossary; reviewed in [18]), has 
finally enabled cardiac biologists to address the long-standing question 
about the functional implications of chromatin topology in cardiac 
pathobiology. The central goal of this review is to provide a critical 
summary of the first series of reports on this topic, most of which have 
emerged during the last five years. We begin by providing a brief 
overview of the state of the art in the chromatin organization field, and 
follow with two main sections describing notable findings and open 
questions in the context of cardiac development and disease, respec-
tively. We conclude by suggesting what we see as promising future di-
rections for the field, including possible paths for the translation of this 
knowledge into clinical practice. 
Throughout this review we focus on studies that specifically pro-
vided insights into the supra-nucleosomal and/or nuclear scale 3D ar-
chitecture of chromatin in cardiomyocytes. Indeed, the topic of cardiac 
chromatin regulation at the nucleosomal scale has been extensively 
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Fig. 1. Chromatin conformation capture technology. 
(A) Basic pipeline for most chromatin conformation capture (3C)-based experiments. Naïve 3D chromatin structure is preserved by crosslinking to stabilize in-
teractions between proteins (grey ovals) and nucleic acids. Chromatin is then fragmented using endonucleases (i.e. restriction enzymes, DNase, or MNase) to generate 
free DNA ends. After end repair, proximity ligation generates hybrid molecules containing DNA regions that may have been far away on the primary sequence (or 
even located on different chromosomes), but were nearby in the 3D space. (B) Specific steps for 3C, 3C on chip (4C), 3C carbon copy (5C), and high-throughput 3C 
(Hi-C). 3C quantifies the interaction between two loci by amplifying a specific proximity ligation product. 4C can capture the interactions between a locus of interest 
and the rest of the genome: proximity ligation products are “trimmed”, re-circularized, and amplified by inverse PCR. 5C can reveal all the contacts in a large genomic 
region: proximity ligation products from restriction enzyme-based 3C are annealed with a complex mix of oligos designed to recognize the regions next to predicted 
cuts sites; oligos facing each other are ligated and amplified. Hi-C can identify any interactions across the genome: proximity ligation products are generated so as to 
incorporate biotin molecules that allow streptavidin-based enrichment of ligation products. 4C, 5C, and Hi-C are nowadays generally analyzed by paired-end next 
generation sequencing (NGS), which allows to map the location of the two DNA fragments contributing to each hybrid molecule obtained after proximity ligation. 
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Fig. 2. Higher order chromatin organization. 
Schematics of the various hierarchical layers of 3D chromatin architecture (left), and exemplative Hi-C chromatin contact heatmaps showcasing the underlying DNA 
interactions (right; each square indicates the interaction frequency between the matching chromosomal coordinates based on a color coding where darker shades of 
red represent stronger interaction). (A) At the nuclear scale, chromosomes mostly occupy specific territories: this is visually indicated by the low degree of inter- 
chromosomal interactions on genome-wide Hi-C maps. (B) At the chromosomal scale, chromatin segregates into megabase-sized active, “A”, and inactive, “B”, 
compartments: this is captured on Hi-C maps by the “checkerboard” interaction pattern within individual chromosomes. (C) At the sub-megabase scale, chromatin is 
subdivided into regions of preferential self-interaction called topologically associating domains (TADs): on finely binned Hi-C maps TADs are identified as “triangles” 
separated by boundary regions. (D) The supra-nucleosomal chromatin architecture within TADs consists of various loop-shaped structures: these are identified as 
“spots” on high-resolution Hi-C maps. 
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concepts and present key findings as accessibly as possible, we 
encourage non-specialist readers to take advantage of the glossary and 
the list of abbreviations provided. 
2. Three-dimensional chromatin architecture 
Studies over the last decade have shown that interphase (non- 
mitotic) chromosomes organize into hierarchical domains at different 
genomic scales (Fig. 2; reviewed more extensively in [22–24]). At the 
highest order of nuclear architecture, individual chromosomes prefer-
entially occupy specific regions called “chromosome territories” 
(Fig. 2A). The relative positioning of such territories is quite conserved 
in different cell types, with small, gene-rich chromosomes and large, 
gene-poor chromosomes forming two separate clusters [25]. At this 
scale, gene expression correlates with the positioning of loci with respect 
to specialized nuclear “neighborhoods”. Thus, while vicinity to hetero-
chromatin environments like nuclear lamina-associated domains (LADs) 
or nucleolus-associated domains is linked with low gene expression, 
proximity to active euchromatin domains such as nuclear speckles fos-
ters gene transcription [26,27]. These domain types also tend to differ 
both in their genomic composition and histone marking. For instance, 
LADs are generally gene poor and enriched for repressive histone marks 
[28]. Nevertheless, LADs are quite heterogeneous, including both re-
gions of constitutive (i.e. stable, generally housekeeping) and facultative 
(i.e. reversible, generally cell type-specific) heterochromatin. While the 
majority of DNA interactions generally occur within individual chro-
mosomes (intra-chromosomal, or in cis), interactions across chromo-
somes (inter-chromosomal, or in trans) can account for up to half of all 
contacts in certain cell types [29]. Recent work has shown that in ol-
factory neurons multiple active enhancers located on different chro-
mosomes (imaginatively named “Greek islands”) form a multi-enhancer 
hub in trans that transcriptionally activates one specific olfactory re-
ceptor gene [30–32]. This example highlights the potential functional 
relevance of bona fide trans chromatin interactions, which have so far 
been difficult to distinguish from background noise arising from the 
random intermixing of nuclear material during proximity ligation 
assays. 
At the sub-chromosomal level, megabase-sized chromatin domains 
broadly segregate into two mutually exclusive “compartments”, 
customarily referred to as “A” (active) and “B” (inactive) [25,33] 
(Fig. 2B). The A compartment generally contains highly-accessible, 
gene-rich regions characterized by active histone marks (i.e. 
H3K36me3, H3K79me2, H3K27ac, and H3K4me1). In contrast, the B 
compartment tends to be compacted, gene-poor, and decorated with 
repressive histone marks (i.e. H3K27me3 and H3K9me3) [25,34]. 
Chromatin domains from different chromosomes characterized by A 
compartmentalization tend to also preferentially interact in trans, and to 
be localized within the nuclear interior. On the contrary, the B 
compartment is not enriched for trans interactions, and these domains 
are generally associated with the nuclear lamina. Indeed, the B 
compartment is thought to contain the majority of LADs [35,36]. Thus, 
compartmentalization is directly linked to the organization of nuclear- 
scale chromatin topology [29,35–38]. The mechanisms that control 
chromatin compartmentalization are only partially understood, but it 
seems that they converge to dictate liquid-liquid phase separation of 
heterochromatin from the rest of nuclear plasma containing the 
euchromatin [39–41]. Combined with the anchoring of heterochromatin 
at the nuclear periphery by nuclear lamina proteins, these biophysical 
forces determine the “classic” radial separation of A and B compart-
ments at the nuclear interior and periphery, respectively, observed in 
most cell types [42]. Notably, at least 20% of the genome shows cell- 
specific compartmentalization [43–47], indicating a substantial degree 
of dynamicity during differentiation and, possibly, disease. 
At the sub-megabase scale, chromatin is organized into regions of 
preferential intra-domain interaction called topologically-associating 
domains (TADs; Fig. 2C) [43,48]. TADs are largely stable between 
different cell types, highly conserved across species, and often regarded 
as basic units of chromosome folding [49]. Indeed, TADs are the 
Fig. 3. Dysregulation of 3D chromatin organization. 
Examples of potential mechanisms by which genetic and environmental factors may functionally affect chromatin topology. (A-B) Post-transcriptional modifications 
(A) or mutations (B) in enhancers may disrupt long-range gene regulation, for instance by preventing binding of a loop mediator. (C-D) Cytogenetic abnormalities 
such as translocations, inversions, or copy number variations may change TAD architecture by generating new boundaries (C) or by removing existing boundaries 
(D). The resulting changes in the topological constraints of regulatory regions (i.e. enhancers) may lead to inappropriate gene regulation. (E) Aneuploidies may affect 
the relative positioning of chromosome territories with respects to active and inactive nuclear neighborhoods. 
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building blocks of the A and B compartments, which are the result of 
inter-TAD interactions, as well as of other chromosomal neighborhoods 
(i.e. peripherally-localized TADs that contribute to LADs; reviewed in 
[50]). The formation of TADs generally relies on the interplay of two 
highly conserved factors: cohesin and CTCF. Cohesin is a ring-shaped 
complex that was initially identified as a mediator of sister chromatid 
cohesion [51]. CTCF uses distinct combinations of its 11 zinc-finger 
domains to interact with other proteins and to bind across the genome 
in a sequence-specific manner [52]. TADs are formed by “extrusion” of 
chromatin by the cohesin complex, which pulls a fragment of chromatin 
within the ring to form a loop [53,54]. DNA extrusion progresses until 
cohesin encounters a physical barrier (i.e. a “TAD boundary”), often a 
CTCF bound site [55,56]. CTCF binding motifs are not palindromic, and 
their orientation plays an important role in controlling the length of an 
extruded loop. While convergent CTCF motifs (i.e. forward- versus 
reverse-oriented) are typically found at the anchors of small loops, a 
divergent direction (i.e. forward-forward or reverse-reverse) is 
frequently observed at TAD boundaries [57]. Importantly, not all TAD 
boundaries are CTCF-dependent, as in other instances cohesin- 
dependent loop extrusion can be halted by the RNA polymerase ma-
chinery in the context of highly transcribed genes [58]. At least in some 
cases the organization of genes and regulatory regions within TADs 
ensures the appropriate cross-talk between enhancers and promoters, 
participates in the preservation of gene expression patterns, and facili-
tates gene co-regulation [59–61]. Notably, alteration of TAD boundaries 
due to copy number variations or expansion of short tandem repeats can 
lead to congenital developmental disorders [62–64] (Fig. 3C-D). More-
over, CTCF/cohesin binding sites are often mutated in cancers [65], 
possibly leading to TAD alterations. On the other hand, certain loci are 
robust to perturbations of TAD structure [66], and acute disruption of 
cohesin-dependent TADs has surprisingly limited effects on global gene 
expression [67]. Thus, the exact function of TADs is still being debated. 
Within TADs chromatin is organized into loops involving genomic 
regions that can be hundreds of kb away (Fig. 2D). Loops are formed by 
the 3D folding of the chromatin fiber, the most basic unit of genome 
organization consisting of DNA wrapped around histone octamers to 
form nucleosomes interconnected by linker DNA. Some loops can be 
formed through a CTCF/cohesin-dependent extrusion mechanism. Such 
CTCF-mediated loops are very conserved and are involved in the for-
mation of chromatin environments [68]. Other loops are CTCF- 
independent: these are generally more dynamic and mainly involved 
in direct control of transcription, for instance by mediating enhancer- 
promoter interactions or by promoting the formation of polycomb 
complexes [69]. Loop formation within TADs creates an organization 
that can be markedly cell type-specific. TAD-nested structures include 
sub-TADs, insulation neighborhoods, and frequently interacting regions 
(FIREs). Sub-TADs and insulation neighborhoods have a strong influ-
ence on gene expression by participating in the formation of local 
chromatin microenvironments. While sub-TADs aggregate several loops, 
insulation neighborhoods are typically formed by a CTCF-mediated loop 
to ensure isolation of the contained genes [70]. FIREs are regions with 
significant cis-connectivity located toward the middle of TADs, and are 
strongly enriched with active enhancers and super-enhancers (i.e. 
clustered enhancer arrays strongly bound the Mediator complex). FIREs 
are strongly tissue-specific, and their activity has been related to the 
















































Fig. 4. Chromatin topology dynamics during cardiac 
development. 
Developmental changes in gene expression during 
cardiogenesis can be associated with multi-scale 
changes in 3D chromatin organization. (A) Cardiac 
gene promoters are often involved in dynamic long- 
range chromatin interactions with repressive do-
mains in the pluripotent state, and with enhancer 
clusters after differentiation. (B) Selected TADs also 
restructure, with novel cohesin-enriched boundaries 
appearing nearby upregulated cardiac genes (arrow). 
On the other hand, pluripotency-specific boundaries 
induced by the transcription of endogenous retroele-
ments of the HERV-H family are lost upon silencing of 
such elements. As a result, the enhancer activity of 
HERV-H on nearby pluripotency genes is weakened. 
(C) At the nuclear scale, transition of certain cardiac 
genes to from the inactive, B, to the active, A, 
compartment is reflected by gene repositioning from 
the nuclear lamina to the nuclear interior. Alternative 
lineage genes (i.e. neuronal or hepatocyte-specific) 
can follow an opposite transition. In specific cases, 
cardiac genes found on distinct chromosomes may 
occupy the same chromatin neighborhood (magnified 
inset), a process that relies on nucleic acid-binding 
proteins targeting such loci and/or their transcrip-
tional output. In B and C, Roman numerals point at 
specific genomic regions to facilitate the comparison 
of chromatin folding patterns in pluripotent cells and 
cardiomyocytes.   
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tissue function [46]. Organizational variability of these local structures 
contrasts with TAD-level consistency across cell types, and suggests that 
lineage-specific genome regulation is controlled primarily by unique 
topological signatures established at this fine level of chromatin orga-
nization [71]. 
3. Chromatin architecture dynamics during cardiac 
development 
Developmental changes in chromatin organization have now been 
reported in multiple lineages [43–47]. Here we examine how cardio-
genesis impacts the various levels of chromatin organization described 
in the previous section, zooming back out from the fine supra- 
nucleosomal scale all the way to the nuclear scale (Fig. 4). 
3.1. Long range chromatin interactions 
Functional interactions between cardiac promoters and distal regu-
latory regions during heart development have been the focus of many 
classical genetics studies. However, the hypothesis that these result from 
physical chromatin interactions lacked experimental validation until 
recently. Application of 3C technology revealed that this is indeed often 
the case. For instance, 3C experiments demonstrated that in cardiac 
progenitor cells the Isl1/Ldb1 complex promotes long-range enhancer- 
promoter interactions, including those involving the core cardiac tran-
scription factors Hand2 and Mef2c [72]. 
More recently, two groups independently reported the first genome- 
wide maps of promoter interactions in cardiomyocytes differentiated 
from human pluripotent stem cells (hPSC-CMs; from either embryonic 
stem cells [hESCs] or induced pluripotent stem cells [hiPSCs], both of 
which are valid in vitro models to study human development [73,74]). In 
both cases the authors performed promoter capture after high- 
throughput chromosome conformation capture (PCHi-C), a method in 
which genome-wide proximity ligation products are enriched for 
promoter-interacting regions through capture by a large number of 
probes [75]. Choy et al. performed PCHi-C on hESC-derived car-
diomyocytes (hESC-CMs) and identified ~180,000 cardiac promoter 
interacting regions (cPIRs) for coding or non-coding genes [76]. They 
found that cPIRs interfacing with transcriptionally active promoters 
were significantly enriched in active histone marks (H3K4me3 and 
H3K36me3), while those engaging with inactive promoters were 
enriched for the repressive mark H3K27me3. Moreover, cPIRs signifi-
cantly overlapped with validated cardiac enhancers and with left ven-
tricular expression quantitative trait loci (eQTLs, pairs of genes and 
single nucleotide polymorphisms [SNP] in which the expression of a 
gene is associated with the allelic configuration of the matching SNP). 
However, such overlaps were relatively modest (~11% and ~7%, 
respectively). Interestingly, validation experiments for a putative 
enhancer overlapping with a cPIR for the gene EDNRA revealed an un-
expected repressive role, showcasing the importance of orthogonal as-
says and functional validation in the interpretation of this data type. 
Montefiori et al. performed PCHi-C from hiPSCs and hiPSC-derived 
cardiomyocytes (hiPSC-CMs), identifying ~400,000 significant pro-
moter interactions in each condition [77]. Key findings regarding long- 
range chromatin interactions included: (1) both cPIRs and hiPSC PIRs 
involved distal regions (median distance of 170 kb) and were strongly 
enriched for the CTCF binding motif, confirming its central role in long- 
range chromatin organization; (2) nearly half of cPIRs were not 
observed in hiPSCs, indicating substantial dynamicity of long-range 
regulatory interactions during cardiogenesis; (3) cPIRs and hiPSC PIRs 
were modestly enriched for motifs of lineage-specific transcription fac-
tors (such as MEIS1 and OCT4, respectively), indicating that these may 
contribute to developmental chromatin dynamics; (4) cardiac-specific 
PIRs were enriched in cardiac-specific H3K27ac domains, compared to 
hiPSC-specific ones, and depleted for cardiac-specific H3K27me3, sug-
gesting that cardiac differentiation drives both engagement of novel 
enhancers and decommissioning of regulatory domains that are inactive 
or poised in hiPSCs. Correlation of cPIRs with left ventricle eQTLs 
confirmed a significant association, though only ~12% of eQTL-gene 
interactions could be validated from promoter interaction data, simi-
larly to what was observed by Choy et al. 
Long-range chromatin interactions can also be determined in an 
unbiased fashion from standard Hi-C (i.e. without promoter capture) if 
the sequencing depth is very high. In their original preprint [78], Zhang 
et al. analyzed chromatin looping from their deeply sequenced Hi-C data 
at multiple stages of hESC differentiation into ventricular car-
diomyocytes (~1 billion unique long-range interactions per point). 
Overall, they found ~14,000 significant chromatin loops at 10 kb res-
olution, 70% of which involved promoter-promoter or promoter- 
enhancer interactions, and 23% of which showed stage-specific 
strengthening and enrichment for motifs of relevant TFs. Interestingly, 
the GATA4 motif was enriched already at two days of differentiation, 
suggesting that it may be important in the early reorganization of 
chromatin during cardiogenesis (possibly because of its pioneering 
factor activity), while MEF2C was enriched only in day 80 ventricular 
hESC-CMs. The authors also identified that exit from the pluripotent 
state involved abrupt loss of loops enriched for H3K27me3 and 
appearance of H3K27ac-marked loops, suggesting an interaction switch 
from inactive or poised regulatory regions to active enhancers. More-
over, enhancers were characterized by strong interconnectivity specif-
ically in the context of TFs (e.g. the HAND2 locus) and not of 
housekeeping genes. These findings reinforce the conclusions of Mon-
tefiori et al. regarding the decommissioning of poised or inactive en-
hancers and the engagement of novel activating enhancers during 
cardiogenesis, and indicate that this mechanism leads to a multi- 
enhancer architecture that may ensure consistent expression of certain 
key cardiac TFs. 
Direct experimental support to the model of enhancer cooperativity 
in the regulation of cardiac TFs expression comes from the aforemen-
tioned study of the role of Isl1/Ldb1 in promoter enhancer interactions 
in cardiac progenitors [72]. Indeed, the Mef2c anterior heart field 
enhancer was shown to interact with and promote the expression of 
multiple other key cardiac development genes in a Ldb1-dependent 
fashion. Further evidence of enhancer cooperativity also in the context 
of cardiac ion channels is provided by a recent report which demon-
strated that SCN5A expression is exquisitely sensitive to multiple 
downstream regulatory regions which act cooperatively as a super- 
enhancer [79]. Such super-enhancer controls the topology of the 
neighboring region, and is essential for normal cardiac conduction and 
embryonic development. Enhancer- and super-enhancer-enriched car-
diac-specific FIREs have been identified in Hi-C data from human left 
and right ventricle [46], but their dynamicity and functional role during 
cardiogenesis has not yet been explored. Overall, it appears that dy-
namic changes in cooperative long-range chromatin interactions may be 
key to the regulation of stage-specific gene expression during cardio-
genesis. CTCF may have a critical role in the formation of such regula-
tory chromatin loops, but there may be other players. For instance, the 
transcriptional and architectural modulator Yy1 mediates enhancer- 
promoter looping during mouse cardiac development [80], possibly 
through Ctcf-independent stalling of cohesin extrusion and/or through 
Yy1 dimerization [81,82]. Importantly, most Hi-C-predicted promoter 
interactions await functional validation. Therefore, the pervasiveness 
and mechanisms of developmental gene regulation by cis chromatin 
interactions remain areas of active investigation. 
3.2. Topologically associating domains 
Moving beyond the 10-200 kb scale, we and others examined TAD 
dynamics during human cardiogenesis [29,58]. In Bertero et al. we 
generated genome-wide chromatin contact maps during cardiac differ-
entiation of hESCs and hiPSCs using Hi-C. We observed that ~70% of 
CTCF-enriched TAD boundaries are stable throughout cardiac 
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specification[29], confirming earlier reports that TADs are generally 
quite conserved across cell types [46]. Moreover, correlating Hi-C with 
RNA-seq revealed that TAD dynamicity had only a minimal effect on 
global gene expression. Differences were observed only in the context of 
regions that acquired a new TAD boundary in hESC-CMs, which corre-
lated with significant upregulation of the closest gene. However, we did 
not test whether such correlation implied causality. A recent report 
suggested that during mouse cardiac development the expression of 
Hand2 is negatively regulated by a nearby long non-coding RNA, 
Handsdown, through a mechanism that may involve reorganization of 
the local TAD structure [83]. However, dynamic changes in the chro-
matin interactions involving the Handsdown locus were independent 
from changes in Ctcf binding, arguing against a change in TAD bound-
aries. Moreover, the authors did not examine the overall chromatin ar-
chitecture of the locus using Hi-C. Thus, whether developmental TAD 
dynamics can be functionally linked to activation of cardiac genes re-
mains currently unclear. 
Zhang et al. also examined TAD dynamics during in vitro cardio-
genesis using the aforementioned deeply-sequenced Hi-C maps [58]. 
Their dataset included mature ventricular hESC-CMs, purified after 80 
days of differentiation using a genetic fluorescent reporter. They 
observed that TAD numbers decreased during differentiation by 20%- 
40% (depending on the TAD identification algorithm used). This 
happened in two waves of approximately equal magnitude: first after 
exit from pluripotency, and secondly during cardiac maturation and 
ventricular specification. The authors determined that TAD boundaries 
lost during early differentiation were adjacent to the H family of human 
endogenous retroviruses (HERV-H), which were strongly transcribed in 
hESCs and promoted the expression of upstream genes. Specific HERV-H 
sequences were also shown to be necessary and sufficient to create TAD 
boundaries, possibly by interfering with DNA extrusion. On the other 
hand, the mechanism that dictates the loss of additional TADs during 
maturation of ventricular cardiomyocytes and its functional implica-
tions remain an open question. 
A crucial role for the chromatin organizers CTCF and cohesin during 
cardiogenesis was established by multiple loss of function studies. Ctcf 
knockout in murine Nkx2.5-positive cardiac progenitor cells was shown 
to lead to myocardial thinning and enlargement, pericardial edema, and 
embryonic lethality at approximately embryonic day 12.5 [84]. This did 
not result from overt changes in cardiomyocyte proliferation or 
apoptosis, but rather from dysregulation of the balance between cardiac 
development and maturation. On the one hand, Ctcf knockout upregu-
lated cardiac maturation genes involved in protein translation and 
mitochondrial oxidative phosphorylation, and led to premature sarco-
mere assembly. On the other hand, developmental regulators were 
downregulated. Intriguingly, Ctcf binding proved different for the two 
classes of genes: upregulated genes showed Ctcf binding close to the 
transcription start sites, suggesting that in this context Ctcf could act as a 
repressor by inducing intragenic looping [85] or via other mechanisms, 
while downregulated genes interacted with distal Ctcf sites located on 
cardiac enhancers, indicating that in this case Ctcf may act as an acti-
vator by promoting enhancer-promoter interactions. A recent study 
found that Trim33, another gene essential for early mouse heart devel-
opment, often interacts with Ctcf on cardiac enhancers, further sup-
porting the importance of Ctcf loops in the positive regulation of cardiac 
developmental genes [86]. A specific subset of the cohesin complex was 
also recently reported to be essential for heart morphogenesis. Indeed, 
global knockout of Stag2, but not its homologous Stag1 [87], impaired 
atrial and ventricular septation, right ventricle development, and 
outflow tract morphogenesis [88]. Distinctly from the Ctcf knockout 
model, this phenotype appeared to result from the combination of 
reduced cellular proliferation and defective migration of second heart 
field progenitors. Heterozygous loss of the cohesin loading factor Nipbl 
was also shown to induce atrial septal defects in mice and zebrafish 
[89,90], which was proposed to result from the defective expansion of 
second heart field cardiac progenitors [91]. In summary, CTCF and 
cohesin are both key players during cardiogenesis, but they seem to act 
through partially non-overlapping mechanisms. It remains unknown 
whether control of higher order chromatin architecture by CTCF/ 
cohesin beyond facilitation of long-range interactions has important 
functional effects during cardiac development. 
3.3. Chromatin compartmentalization 
Beyond the megabase scale, multiple groups provided important 
insights into changes in active versus inactive (A/B) chromatin 
compartmentalization during cardiogenesis. We found that during car-
diac differentiation of hESCs and hiPSCs ~20% of the genome shows 
dynamic compartmentalization [29]. For ~80% of such regions, 
changes in compartmentalization occurred in a single direction (i.e. B to 
A or A to B; ~50% and ~30%, respectively), with only few domains 
showing a transient switch (i.e. B-A-B or A-B-A). This was in striking 
contrast with the highly stage-specific gene expression signatures during 
differentiation. Accordingly, the correlation between gene expression 
changes and compartmentalization dynamics was generally limited. A 
notable exception to this were regions transitioning from B to A, which 
were strongly enriched for heart development genes upregulated during 
cardiogenesis. Similar observations were made in other studies exam-
ining cardiac differentiation of hPSCs [58,77], as well as in the context 
of mouse heart development [92], confirming the in vivo relevance of 
these mechanisms. 
Intriguingly, we found that compared to other upregulated genes loci 
transitioning from B to A during human cardiogenesis were larger 
(median size > 100 kb), more isolated from nearby genes, and more 
cardiac specific, all characteristics that may facilitate control of gene 
expression via large-scale chromatin topology rearrangements with high 
specificity and minimal requirement for additional regulatory layers 
[29]. A notable example for this regulation was TTN, encoding the 
largest human protein, titin. By performing 3D DNA fluorescence in situ 
hybridization (FISH) we further demonstrated that the B to A transition 
of TTN corresponded to repositioning of the locus from the nuclear pe-
riphery to the nuclear interior. An analogous topological rearrangement 
was independently reported during mouse embryonic stem cell differ-
entiation by the Jain and Epstein labs, which described the release of key 
cardiac loci from bona fide LADs enriched with the repressive histone 
mark H3K9me2 [26,93]. They also found that in this context anchoring 
of cardiac loci to the nuclear lamina relied on the histone deacetylase 
Hdac3, though intriguingly it did not require its enzymatic activity [26]. 
Impairment of this mechanism due to Hdac3 inducible knockout led to 
premature cardiac differentiation, while upregulation of Hdac3 
impaired cardiogenesis, indicating a correlation between release of 
cardiac loci from the nuclear lamina and the cardiogenic potential of 
mouse embryonic stem cells. Notably, Hdac3 was previously shown to 
promote mouse secondary heart field development by epigenetically 
repressing Tgfβ1 expression in a deacetylase-independent manner [94], 
though no connections with chromatin organization were made at the 
time. 
While examining regions of increased chromatin accessibility within 
B to A domains in hESC-CMs, we observed a strong enrichment for 
binding motifs of the core cardiac TFs GATA4, NKX2-5, and TBX5 [29]. 
Moreover, GATA4 already bound such regions in cardiac progenitors, 
suggesting that it may represent a pioneer factor that contributes to the 
release of these genomic loci from the repressive environment of the 
nuclear lamina (an hypothesis that still requires experimental valida-
tion). By contrast, we observed loss of CTCF binding in at least some B to 
A genes (i.e. TTN), which corresponded to decreased intragenic chro-
matin interactions. Overall, activation of topologically-regulated car-
diac genes may result from the interplay of epigenetic remodelers (such 
as HDAC3), transcriptional regulators (possibly GATA4), and chromatin 
organizers (possibly CTCF), whose dynamic binding or release leads to 
chromatin repositioning from the lamina to the nucleoplasm, decreased 
gene compaction, and transcriptional activation. However, the order 
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and causal relationship between these events remains to be clarified, as 
does the precise identity of the trans-acting factors involved. 
Chromatin switching from A to B during hPSC-CM differentiation 
proved to be largely independent of gene expression changes [29]. 
Nevertheless, as described in more detail in Section 4.1 below, we 
subsequently observed that in hiPSC-CMs haploinsufficient for lamin A/ 
C impairment of A to B transitions corresponded to incomplete segre-
gation of non-cardiac loci from the nucleoplasm to the nuclear lamina, 
and in some cases led to their ectopic expression in hiPSC-CMs [95]. 
Along the same lines, in Chapski et al. we found that in mouse car-
diomyocytes the A compartment was comparatively depleted of non- 
cardiac (liver) genes compared to hepatocytes, which could “tolerate” 
the presence of cardiac genes in the active compartment while main-
taining tissue-specific regulation [96]. Moreover, 3D models of chro-
matin compartmentalization indicated that only cardiomyocytes 
radially segregated the A and B compartments towards the nuclear 
interior and periphery, respectively [96]. This suggests that car-
diomyocytes rely more strongly on topological silencing of alternative 
lineage loci at the nuclear lamina than other differentiated cell types. In 
other words, as recently proposed by Jain and Epstein, chromatin 
compartmentalization may define cardiac cell fate competence [97]. 
However, to date this model has not been formally tested by varying A/B 
compartmentalization independently of gene expression (for instance by 
forcing nuclear lamina or nucleoplasm localization of a given locus 
without altering the activity of the trans-acting regulators involved in 
nuclear lamina localization or release). 
DNA methylation has been unveiled as a reliable predictor of A/B 
compartmentalization [98]. Strikingly, Nothjunge et al. [92] showed 
that the organization of A/B compartments precedes the establishment 
of DNA methylation patterns during cardiomyocyte differentiation. 
Moreover, A/B compartmentalization was not altered after ablation of 
the two enzymes responsible for de novo methylation (Dnmt3A and 
Dnmt3B). On the other hand, DNA methylation is an established 
modulator of CTCF binding [99–101]. Moreover, a recent report 
demonstrated that impairment of DNA demethylation in the heart 
(double knockout of Tet2 and Tet3) disrupts binding of Yy1, impairing 
long-range chromatin interactions [80]. Therefore, while DNA methyl-
ation seems dispensable for nuclear-scale organization of cardiac chro-
matin, it plays an important and only partially understood regulatory 
role at the level of TADs and chromatin loops (Fig. 3A). 
3.4. Chromosomal organization 
Nuclear dynamics up to the gigabase scale are only beginning to 
emerge. We found that during cardiac differentiation of hESCs the 
relative proportion of interactions between chromosomes (inter-chro-
mosomal, or in trans) increased from ~30% to ~50% [29]. Despite this, 
the relative topology of chromosome territories was overall maintained. 
Throughout differentiation, trans chromatin interactions were enriched 
in the A compartment and depleted in the B. Interestingly, Hi-C from 
mouse cardiomyocytes revealed that significant trans interactions were 
markedly enriched for cardiac-specific genes (and not liver-specific 
genes), suggesting that at least some trans interactions may be associ-
ated with the formation of functional chromatin neighborhoods [96]. 
Supporting this notion, we found that during hESC-CM differentia-
tion several cardiac loci from at least 10 different chromosomes formed 
a trans-interacting chromatin domain centered around the gene TTN 
[29]. We further identified that these trans interactions were dependent 
on a common splicing factor, RBM20, which formed foci proximal to the 
TTN gene and nucleated by its many binding sites onto the TTN pre- 
mRNA. Preventing TTN transcription not only disrupted this chro-
matin feature, but also had a trans-acting effect on the alternative 
splicing of other RBM20 target genes. This suggests that RBM20 foci at 
the TTN loci represent cardiac-specific splicing factories that arise from 
specific inter-chromosomal chromatin associations. It has been proposed 
that cooperative binding of transcriptional and epigenetic regulators 
may lead to spatial clustering of their shared targets into specialized 
transcription factories [102]. However, the existence of multiple non- 
random transcription factories with some degree of structural stability 
has not been yet established. Indeed, the lack of robust methods to 
identify and validate significant trans chromatin interactions remains an 
important bottleneck in the field. 
4. Chromatin architecture dynamics in cardiac disease 
Emerging evidence implicates disruption of chromatin architecture 
in the pathogenesis of multiple diseases (recently reviewed in [103]). 
Here we examine our current knowledge about the impact of disease- 
causing gene mutations, genetic variants, and environmental factors 
on chromatin organization in cardiomyocytes. 
4.1. Monogenic disorders 
Studies of 3D chromatin organization changes in cardiac monogenic 
diseases have so far largely focused on DCM due to heterozygous LMNA 
mutations (Fig. 5). LMNA encodes lamin A and lamin C (henceforth 
lamin A/C), two key components of the nuclear lamina that can interact 




















Fig. 5. Chromatin topology rearrangements in cardiac laminopathy. 
Nonsense and missense heterozygous mutations in LMNA have distinct effects on the 3D chromatin architecture of cardiac myocytes. Nonsense mutations that lead to 
Lamin A/C haploinsufficiency (center) disrupt the sequestration into the B compartment of specific non-cardiac loci. In some cases, this results in ectopic expression 
(i.e. the neuronal P/Q-type calcium channel CACNA1A). Regulatory mechanisms other than compartmentalization changes lead to the inefficient silencing of some 
cardiac progenitor genes (i.e. the tyrosine kinase receptor PDGFRB) and to the upregulation of certain cardiac genes (i.e. the L-type calcium channel CACNA1C). 
Missense mutations in lamin A/C (right) that strengthen the association of chromatin with the Polycomb Repressive Complex 2 (PRC2) lead to increased peripheral 
localization and downregulation of specific cardiac genes (i.e. the fast sodium channel SCN5A). In both contexts, aberrant gene expression contributes to disease- 
associated electrophysiological abnormalities. 
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discovery that mutations in LMNA can cause striated muscle pathology 
[106], it was proposed that this may be at least partially explained by 
pathological alterations in chromatin architecture. Early work in 
patient-derived fibroblasts reported repositioning of chromosomes 13 
and 18 from the nuclear periphery to the interior [107]. A subsequent 
report observed a similar mislocalization of two proximal gene clusters 
on chromosome 13, which was associated with decondensation of the 
local genomic region and upregulation of gene expression both in fi-
broblasts and in the heart [108]. More direct evidence for lamin A/C in 
the regulation of cardiac chromatin architecture came from studies in a 
mouse cardiomyocyte cell line, which showed that knockdown of lamin 
A/C reduced the peripheral localization of three randomly-selected 
lamin A/C-bound loci [109]. Interestingly, however, none of such 
genes were upregulated, indicating that topological rearrangements of 
chromatin were insufficient for transcriptional activation. 
More recently, three studies examined changes in association of 
chromatin with the nuclear lamina in LMNA DCM using patient-derived 
hiPSC-CMs [110,111] and primary cardiomyocytes [112]. Lee et al. 
studied a haploinsufficient hiPSC model of arrhythmogenic LMNA DCM 
(K117fs) [110]. Lamin A/C association was altered for ~25% of all LADs 
and involved both decreased and increased occupancy (accounting for 
~5% and ~2% of the genome, respectively). These dynamic LADs were 
also relatively short, with a mean size of ~250 kb (compared to ~1.5 Mb 
for unaffected LADs). Importantly, ~80% of the 250 differentially 
expressed genes were located outside of LADs, while LADs lost or ac-
quired in mutant hiPSC-CMs contained only ~2% and ~4% of all 
differentially expressed genes, respectively, which were mostly upre-
gulated in both cases. Mechanistically, the authors found that abnormal 
activation of PDGF signaling due to upregulation of the receptor gene 
PDGFRB led to arrhythmic manifestations. PDGFRB is normally 
expressed in cardiac progenitors, and its incomplete silencing in mutant 
hiPSC-CMs was mirrored by increased active histone marks and chro-
matin accessibility at its promoter. However, this was not associated to 
changes in lamin A/C association. Accordingly, PDGFRB is constitutively 
located in the A compartment throughout cardiac differentiation of 
hPSCs [29], implying that its transitory upregulation in cardiac pro-
genitors and subsequent downregulation in hPSC-CMs must rely on 
mechanisms other than broad rearrangements of chromatin compart-
mentalization. Overall, this work showed that while lamin A/C hap-
loinsufficiency leads to selective changes in LAD topology and gene 
upregulation, the majority of gene expression changes occurs in other 
genomic regions. 
In Salvarani et al. [111], we studied a distinct hiPSC model of LMNA 
DCM caused by a heterozygous missense mutation in the rod domain of 
lamin A/C (K219T) and characterized by impairment in cardiac con-
duction. This was mechanistically associated with epigenetic silencing 
of the fast sodium channel gene SCN5A, which proved to be more closely 
associated to the nuclear lamina and more strongly enriched with Pol-
ycomb Repressive Complex 2 (PRC2) and H3K27me3. Interestingly, 
similar results were obtained in the context of another heterozygous 
missense mutation located in the same domain of lamin A/C (R190W). 
These results suggested that certain missense mutations in LMNA may 
have dominant negative effects that can lead to gene silencing. How-
ever, this study did not address global changes in LADs, and therefore 
the pervasiveness of this mechanism at the genome wide level mecha-
nism remains unclear. 
Cheedipudi et al. examined lamin A/C association of chromatin and 
gene expression changes in cardiomyocyte nuclei isolated from the 
hearts of LMNA DCM patients undergoing cardiac transplantation [112]. 
Five patients were analyzed, four with missense mutations in the rod 
domain (two with R166P, and one each with G312H or R335W) and one 
with a nonsense mutation truncating the rod domain (G353X). When 
comparing the aggregated list of LADs from patients with LADs from five 
control healthy individuals, the authors found differences on regions 
collectively accounting for ~10% of all coding genes. Interestingly, 
control-specific LADs accounted for a total of 95 Mb, while LMNA DCM- 
specific LADs accounted for 539 Mb. Whether missense and nonsense 
mutations led to similar or distinct LAD dynamics was not reported. In 
general, gain and loss of LADs was associated with lower and higher 
gene expression, respectively. Nevertheless, only ~15% and ~5% of 
differentially expressed genes were found in gained and lost LADs, 
respectively, once again indicating that a majority of gene expression 
changes in LMNA DCM does not involve LAD dynamics. Differentially 
expressed genes found in dynamic LADs were largely specific for LMNA 
DCM compared to non-LMNA DCM, indicating that they could include 
genes associated to the particularly severe manifestations of LMNA DCM 
[14–17]. It is worth pointing out that Lee et al., Salvarani et al., and 
Cheedipudi et al. all relied on chromatin immunoprecipitation (ChIP) 
for lamin A/C to define LADs. However, considering that in all models 
lamin A/C was downregulated and/or mutated, it is not clear whether 
such ChIP-defined domains correspond to bona fide LADs (i.e. periph-
erally located regions also interacting with other nuclear lamina pro-
teins such as B-type lamins and the lamin B receptor, LBR [113]). While 
Salvarani et al. provided validation of SCN5A mislocalization by DNA 
FISH, this or other orthogonal assays were not implemented by Lee et al. 
and by Cheedipudi et al. 
In Bertero et al. we used Hi-C to examine genome-wide changes in 
chromatin organization in a hiPSC model of LMNA DCM due to lamin A/ 
C haploinsufficiency (R225X) and characterized by irregular and slower 
beat rate and prolonged calcium transients [95]. Surprisingly, A/B 
compartment changes involved only ~1% of the genome. Chromatin 
domains normally in B but found in A in mutant hiPSC-CMs were 
enriched for regions that during cardiogenesis transition from A to B, 
and DNA FISH confirmed that such domains were generally localized 
further away from the nuclear lamina in mutant cells. Notably, however, 
genes in most of these domains were not differentially expressed. We 
found that in mutant hiPSC-CMs only three genomic hotspots were 
characterized both by ectopic retention in the A compartment and 
modest upregulation of some genes contained within. Such genes were 
strongly enriched for neuronal factors, such as the P/Q-type calcium 
channel CACNA1A. We found that this gene aggravated the electro-
physiological abnormalities in mutant hiPSC-CMs, suggesting that 
inappropriate silencing of specific neuronal genes due to lamin A/C 
haploinsufficiency may contribute to the pathogenesis of LMNA DCM. 
These findings provide further support for the conclusion that lamin A/C 
haploinsufficiency can lead to selective disruptions of developmental 
LAD dynamics, but that only some of these result in gene expression 
alterations. On the other hand, we also observed that electrophysio-
logical abnormalities in mutant hiPSC-CMs were primarily caused by 
upregulation of the cardiac L-type calcium channel CACNA1C, which 
was not associated with changes in chromatin compartmentalization 
(similarly to PDGFRB, this gene is constitutively found in the A 
compartment during cardiogenesis). 
All in all these and other studies established that nuclear lamina 
association is not the sole determinant of gene repression at the nuclear 
periphery. Whether lamin A/C impairment leads to selective dysregu-
lation of cardiac progenitor and cardiac genes through more localized 
changes in chromatin organization (i.e. at the level of TADs or looping) 
or via trans-acting effects involving other chromatin regions remains 
unclear. Interestingly, B-type lamins have been shown to indirectly 
affect the expression of lamina-distal genes by modulating inter-TADs 
interactions as a result of altered LADs compaction [36]. If A-type 
lamins played a similar role, their disruption may lead to ripple effects 
throughout multiple layers of 3D chromatin organization. Alternatively, 
A/B compartment-independent gene expression changes may be driven 
by alterations in intracellular signalling pathways with established links 
to the nuclear lamina, such as MAPK and mTOR, which are upregulated 
in animal models of cardiac laminopathy (reviewed in [114]). Overall, 
to what extent changes in chromatin organization represent a key pri-
mary driver of pathology in cardiac laminopathy remains an open 
question. 
Besides LMNA DCM, the potential involvement of 3D chromatin 
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organization in the many other known monogenic cardiac diseases (for 
instance CHD due to mutations in TFs or chromatin modifiers, and 
RBM20 DCM) remains virtually unexplored, and is thus an attractive 
subject for future investigations. 
4.2. Genetic variants 
Over the last decade, large-scale genotyping with classical methods 
or via exome and whole genome sequencing have provided an ever 
growing list of genetic associations to multiple cardiovascular diseases 
(reviewed in [115,116]). Genome-wide association studies (GWAS) 
have revealed that a vast majority of such disease-associated genetic 
variants are non-coding and often located in intergenic regions, and are 
thus not easily interpreted. Since most such variants are believed to 
regulate expression of genes within neighboring regions, integration of 
GWAS with 3C-type data has the potential to allow the identification of 
how disease variants directly interact with their target loci. 
Choy et al., Montefiori et al., and Zhang et al. all explored this 
approach by integrating their long range chromatin interaction maps 
from cardiomyocytes with cardiac GWAS data [76–78]. Choy et al. 
found a modestly significant association (p < 0.045) between significant 
cPIRs and GWAS hits for cardiac conduction and rhythm disorders [76]. 
These included regions that were previously predicted to affect expres-
sion of TFPI, SC35F1, and HCN4, based on their proximity to such genes, 
but which were found to actually interact with ZSWIM2, PLN, and NPTN, 
respectively. Another aspect of note was that the combined use of pro-
moter interactome data and eQTLs allowed the authors to confirm a 
functional interaction between ACTN4 and CAPN12 in correspondence 
to a GWAS peak that did not reach significance in previous studies, 
possibly due to an insufficient study sample size. While none of such 
potential interactions were functionally validated in the study, these 
examples showcase the potential for chromosomal maps to refine GWAS 
predictions beyond what is possible by simply looking at the closest gene 
and/or at known eQTLs. Notably Choy et al. found no significant asso-
ciation between cPIRs and GWAS hits for coronary artery disease, and 
virtually no association with hits for CHD. Both of these phenotypes also 
involve non-cardiomyocyte lineages, which may explain this somewhat 
unexpected finding. However, it is also possible that correlation between 
cPIRs and CHD GWAS hits may become more apparent in analogous 
analyses of cardiac progenitors, which may possess unique and transi-
tory PIRs. 
Montefiori et al. examined the correlation of cPIRs with GWAS hits 
for cardiac arrythmias, heart failure, and myocardial infarction [77]. 
They found that just ~20% of the lead SNPs or the other variants in high 
linkage disequilibrium with the lead SNPs were located in a significant 
cPIR. This indicates that most cardiac GWAS hits may involve rare or 
transient chromatin interactions that are hard to identify with confi-
dence from bulk PCHi-C. Alternatively, the underlying genetic variants 
may affect other cell types or states, and/or act independently of chro-
matin looping. Interestingly, this study revealed that over 90% of 
chromatin interactions between GWAS SNPs and promoters do not 
involve the closest gene, with over 50% of them skipping five or more 
genes. Indeed, the median distance between such interactions was 185 
kb. Moreover, ~40% of SNPs interacted with more than one gene. 
Interestingly, cPIRs overlapping with GWAS SNPs were enriched for 
genes that lead to cardiovascular phenotypes when knocked out in mice, 
suggesting an important and evolutionarily conserved role in cardiac 
gene regulation. 
Zhang et al. found a strong enrichment of GWAS SNPs located in 
chromatin loop anchors (i.e. one of the two interacting regions in a given 
loop) when examining heart rhythm phenotypes, and a moderate 
enrichment in the context of congenital heart disease and coronary heart 
disease [78]. Accordingly, the matching genes were enriched for cardiac 
ion channels and other factors involved in cardiac function. Notably, the 
authors also provided experimental evidence that two of the GWAS 
target predictions based on chromatin looping data proved more 
accurate than the one originally made based on gene proximity alone. 
Indeed, deletion of a SNP-containing enhancer led to reduced expression 
of its interacting locus WNT3 during cardiac differentiation, while it did 
not affect the nearest gene GOSR2. A similar experiment established the 
long-range regulatory function of a SNP-associated enhancer located 
~200 kb away from MSX1 (while this region did not influence expres-
sion of the closest gene STX18). These results provide a strong proof of 
principle and outline a promising pipeline for the validation of cardiac 
GWAS hits through the integration of genome-wide chromatin organi-
zation data. 
Chromatin conformation capture data can also inform GWAS studies 
beyond the interrogation of direct long-range chromatin interactions. 
For instance, a GWAS study for gene modifiers increasing the risk of 
developing Tetralogy of Fallot in patients with DiGeorge syndrome 
relied on TAD maps to predict an interaction between an intronic SNP in 
the gene ADGRV1/GPR98 and the cardiac transcription factor MEF2C 
locus [117]. Since TADs are quite conserved across cell types, the au-
thors leveraged on Hi-C data from non-cardiac cells to identify the TAD 
containing ADGRV1. Then, under the assumption that cis effects of the 
GWAS hit would be restricted within such TAD, they identified MEF2C 
as the most likely transcriptional target within the TAD (also considering 
its established role in heart development and its specific expression in 
the secondary heart field). This approach may prove particularly valu-
able in the many cases where GWAS hits cannot be mapped to long- 
range interactions, and ought to be even more predictive when 
applied to the recently reported cardiomyocyte Hi-C maps. 
Direct evidence of the impact of GWAS-associated long-range chro-
matin interactions and cardiac disease comes from the study of PITX2 
regulation in atrial fibrillation [118,119]. 3C analyses reveled that a 
genomic region containing risk alleles for atrial fibrillation and located 
~170 kb upstream of mouse Pitx2 includes multiple regulatory elements 
that physically interact with the Pitx2 promoter [118]. A subsequent 
study confirmed these observations with circularized chromosome 
conformation capture (4C) analyses, and also demonstrated that dele-
tion of a ~20 kb enhancer within this region leads to reduced Pitx2 
expression and increased atrial fibrillation propensity [119]. Deletion of 
an intronic Ctcf binding site in Pitx2 also had a similar effect, suggesting 
that Ctcf-dependent chromatin looping was required for the enhancer to 
interact with Pitx2 (though this was not formally tested). Another 
example of integrating GWAS and chromatin conformation capture data 
comes from the aforementioned study of the SCN5A super-enhancer 
[79]. The authors identified such enhancer structure by integrating 
hits from a GWAS study of heart rhythm phenotypes, TAD maps, and 
H3K27ac enrichment. They then demonstrated with 4C that the super- 
enhancer interacts with the Scn5a promoter in the mouse. Finally, 
they proved that the super-enhancer is essential for Scn5a transcription 
during development. Notably, they also identified a heart rhythm- 
associated genetic variant within the enhancer whose minor allele 
reduced enhancer activity in response to Gata4 and Nkx2.5 (though such 
evidence was limited to a luciferase reporter assay and not tested at the 
endogenous locus). Finally, a recent study relied on the aforementioned 
high-resolution Hi-C data for hiPSC-CMs of Zhang et al. [58] to func-
tionally annotate a heart failure GWAS hit to an enhancer of the ACTN2 
gene [120]. Notably, such annotation could not be made based on eQTL 
data alone, demonstrating the added value of the Hi-C data. Deletion of a 
~2 kb fragment containing the enhancer reduced ACTN2 expression in 
hiPSC-CMs, confirming its regulatory function. However, it is important 
to note that neither this study nor any of those previously described 
provided evidence that patient-associated disease variants were suffi-
cient to affect the expression of their putative target genes, nor did they 
test whether this was associated with changes in chromatin interactions 
(Fig. 3A). Therefore, while it appears clear that chromatin conformation 
capture data can be effectively leveraged to identify key regulatory el-
ements associated to GWAS hits, the causative role of these genetic 
variants in functional chromatin interactions remains to be established. 
The potential impact of genetic variation on cardiac chromatin 
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structure may go well beyond what can be detected by GWAS. Aneu-
ploidies and copy number variations account for ~25% of all CHD cases 
[121]. Such large scale chromatin rearrangements may have profound 
effects on cardiac nuclear organization, as already shown in other con-
texts such as trisomy 21, cancer, and limb development 
[62,63,122,123]. Thus, future studies may explore whether genetic 
variation impacts not only the formation and activity of long-range 
chromatin interactions, but also higher order chromatin architecture 
at the level of TADs, A/B compartments, and even chromosome terri-
tories (Fig. 3). 
4.3. Environmental stressors 
Cardiovascular disease (CVD) remains the leading cause of death 
globally [124]. CVD risk factors such as high blood pressure, smoking, 
and diabetes, are well known to induce profound transcriptional 
changes in the heart (reviewed in [125]). The pathogenic role of 
epigenetic changes at the level of DNA methylation and histone modi-
fications is also well established (reviewed in [20]). In recent years, 
alterations of 3D chromatin architecture at multiple levels have been 
proposed to also play a role in the adaptation and maladaptation of the 
heart to humoral and mechanical stress. 
At the level of chromatin looping, He et al. demonstrated that pres-
sure overload by transverse aortic constriction (TAC) activates Gata4 
binding at enhancers, subsequently activating gene expression by 
recruitment of p300 and H3K27ac deposition [126]. This process re-
stores Gata4 binding at a subset of fetal enhancers that reactivate the 
fetal gene program, a hallmark of cardiomyopathy. Papait et al. mapped 
cardiac enhancers associated with genes involved in the progression of 
cardiac hypertrophy, and demonstrated that their activity is mediated 
by Mef2 [127]. Although these studies did not directly examine the 
structural dynamics of chromatin, their results suggest that enhancer- 
promoter interactions that control the pathological gene program rely 
on the formation of chromatin loops that are physically mediated by 
cardiac disease-associated transcription factors. 
In the context of genome organizers, in Monte et al. we showed a 
reciprocal regulation of Ctcf and Hmgb2 [128], a non-histone chromatin 
structural protein upregulated after TAC [129]. We found that at the 
same locus Ctcf serves as a boundary to prevent heterochromatin 
spreading (thereby promoting gene accessibility), while Hmgb2 in-
creases DNA compaction and gene repression. Notably, we subsequently 
found that CTCF is downregulated in primary cardiac samples from 
patients with heart failure [130]. These findings suggest that changes in 
the CTCF to HMGB2 ratio allow for varied genomic plasticity. 
At the nuclear scale, in Karbassi et al. [131] we demonstrated that 
cardiac stress due to phenylephrine treatment or TAC increases the 
number or size of RNA Pol II clusters in neonatal or adult car-
diomyocytes, respectively, and also affects their positioning, with the 
most active clusters being found in the nuclear interior. Moreover, we 
found that gene movement towards the nuclear periphery and/or other 
heterochromatic regions correlated with gene repression after TAC (i.e. 
the sarcoplasmic reticulum calcium pump Atp2a2), and vice versa (i.e. 
the stress response gene Nppa). Finally, we showed that chromatin 
structure reorganization after TAC promoted the physical interaction 
between genes that change expression in the same direction, supporting 
a model where the congregation of co-regulated genes coordinates 
transcription during stress. 
We and others recently applied Hi-C to examine the global changes in 
chromatin 3D structure during mouse models of heart failure [130,132]. 
In Rosa-Garrido et al. we examined the effects of Ctcf depletion (as a 
model of chromatin disruption) and of TAC on 3D chromatin architec-
ture in the heart [130]. We generated a cardiac-specific inducible Ctcf 
knockout mouse to selectively deplete Ctcf in the adult heart, and 
observed that this is sufficient to induce heart failure through mecha-
nisms that involve reorganization of genome architecture. Remarkably, 
such changes in chromatin architecture measured were similar to those 
observed after TAC. In summary, we showed that induction of heart 
failure promotes: (1) profound loss of intra-chromosomal interactions, 
reducing the number of chromatin loops and enhancer-promoter con-
tacts by ~20%–25%; and (2) switching of A/B compartmentalization for 
~4% of the genome, which correlated with gene expression changes 
towards the anticipated direction. Interestingly, although widespread 
changes in the strength of TAD boundaries were detected, TAD integrity 
was overall conserved. 
Following a similar approach, Lee et al. independently confirmed 
that cardiac-specific depletion of Ctcf in the mouse leads to heart failure 
and alterations of 3D chromatin architecture [132]. In contrast to our 
earlier observations the authors detected a strong disruption of TADs 
after Ctcf depletion. This discrepancy is likely explained by the different 
methodology used to ablate Ctcf: in Rosa-Garrido et al. we used a 
tamoxifen-inducible Cre-Lox system which downregulated Ctcf by 
~80% at the protein level, while Lee al. delivered Cre via an adeno- 
associated virus and reached nearly complete depletion of Ctcf pro-
tein. These results suggest that some highly-conserved TAD boundaries 
are bound by Ctcf so strongly and/or stably that some degree of chro-
matin structure is retained when Ctcf is not completely depleted (as also 
proposed by others in non-cardiac systems [133]). This notion aligns 
with the results of Nora et al., who used an auxin-inducible degron 
system to demonstrate that while Ctcf is essential for TAD integrity in 
mouse embryonic stem cells, TAD integrity is maintained with as low as 
4% of normal Ctcf expression [134]. Importantly, while CTCF levels 
decrease after induction of cardiac disease in some mouse models and in 
patients with heart failure, CTCF never disappears completely [130]. 
Thus, the approach of Lee et al. is valuable for studying chromatin 
structure dynamics after complete loss of CTCF, while the method used 
in Rosa-Garrido et al. offers a clinically relevant approach to investigate 
changes in high order chromatin with cardiac disease. 
Overall, there is increasing evidence that 3D chromatin organization 
in the adult heart is modulated by and may contribute to heart failure 
due to pressure overload and chronic humoral stimuli. However, the 
causal relationships and underlying mechanisms are yet to be explored 
in detail. Moreover, the effect of other CVD-causing environmental 
stressors on 3D chromatin topology remains an open area for future 
investigation. 
5. Future outlook 
Three-dimensional chromatin organization in cardiac development 
and disease is a young field with many open questions, some of which 
are mentioned throughout the previous sections. Here we summarize 
what we view as other “big picture” areas for future investigation. 
While most studies have so far focused on cardiac myocytes, little is 
known about genome topology dynamics in other cardiovascular cell 
types such as endothelial cells, smooth muscle cells, fibroblasts, and 
immune cells. All of these play key roles in CHD and CVD, undergo 
dramatic phenotypic changes after stress, and represent promising tar-
gets for therapeutic intervention. For instance, it was very recently re-
ported that cardiac fibroblasts undergo a major pathological 
rearrangement of chromatin accessibility in heart failure, which can be 
mitigated by inhibition of bromodomain-containing (i.e. histone lysine 
acetylation-reading) coactivators [135]. Endothelial cells were shown to 
undergo marked changes in 3D chromatin architecture during differ-
entiation [136], further showcasing the potential for phenotypic regu-
lation via genome topology dynamics in non-myocyte cells. 
The genome organization field is rapidly advancing both conceptu-
ally and methodologically. Important areas that deserve particular 
attention are: (1) the integration of biophysics and molecular biology, 
including the recent development of tools to perturb the biophysical 
properties of chromatin [137]; (2) the orthogonal application of imag-
ing- and sequencing-based assays to elucidate 3D chromatin organiza-
tion, particularly the application of single-molecule, super-resolution, 
and highly multiplexed imaging [138,139]; (3) the advances in 
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synthetic biology tools to elucidate the structure-function relationship of 
chromatin, for example by engineering chromatin loops [140], or by 
repositioning loci to specific nuclear sub-compartments [141]; (4) the 
development of single cell assays for chromatin architecture [142], 
including multi-omics approaches to examine multiple layers of nuclear 
function in the same cell [143–145]; and (5) the growing appreciation of 
the key role of non-coding RNAs [146–148] and DNA methylation 
[100,101] in genomic structuring. The timely incorporation of these and 
other innovations in cardiac biology would offer remarkable opportu-
nities to study the functional role of 3D chromatin organization in key 
physiological contexts, such as the most common birth defect (CHD) and 
the leading cause of death in adults (CVD). Going forward, it will be 
particularly important to move from describing and correlating changes 
in chromatin organization due to broad-acting perturbations (an 
approach that by necessity has characterized most studies so far), to 
mechanistically probe the role of individual chromatin structure 
regulations. 
Importantly, we believe that such basic knowledge has a strong po-
tential to inform clinical practice through identification of novel CHD 
and/or CVD biomarkers, clarification of genetic associations for non- 
coding variants, and identification of druggable mechanisms. This last 
goal could be pursued in at least two ways: (1) the use of small molecules 
that modulate the activity of epigenetic modifiers (i.e. histone writers, 
readers, and remodelers) to indirectly affect chromatin looping and 
compartmentalization; (2) the application of CRISPR/Cas9-based gene 
therapy strategies aimed at modulating specific chromatin interactions 
(i.e. deletion of loop anchors or TAD boundaries, or re-wiring of chro-
matin looping or locus compartmentalization; Fig. 6). 
Overall, we think that future work in the field of 3D nuclear biology 
will reveal a novel dimension to our understanding of cardiac pathology 
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Glossary 
Chromosome conformation capture: general methodological framework to study 3D chro-
matin architecture based on the quantification of contact frequencies between regions 
that interact in the 3D space, as revealed by proximity ligation assays (Fig. 1A). 
3C: basic chromosome conformation capture technique to detect physical interaction be-
tween two specific loci (Fig. 1B). 
4C: 3C-derivative technique to detect all interactions between one specific locus and the 
rest of the genome (Fig 1B). 
Hi-C: genome-wide extension of the 3C technique to determine all pairwise 3D genomic 
interactions (Fig 1B). 
Chromatin contact heatmap: graphic representation of 3D interaction frequencies between 
genomic loci. Often plotted as a triangle where the base (x axis) covers a genomic 
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interval and each point on the y axis indicates the interaction frequency of the 
matching genomic coordinates (Fig. 2). 
Chromosome territory: nuclear region preferentially occupied by specific chromosomes. On 
a genome-wide, triangular chromatin contact heatmap, it is indicated by a distinct 
triangular interaction pattern delimiting a given chromosome (Fig. 2A). 
A/B compartmentalization: separation of megabase-sized chromosomal domains within 
active (A) or inactive (B) chromatin environments. On a chromosome-wide, triangular 
chromatin contact heatmap, it is indicated by the “checkerboard” structure building 
upward from the base (Fig. 2B). 
TAD: sub-megabase chromosomal domain characterized by preferential self-interaction. 
On a sub-chromosomal, triangular chromatin contact heatmap it appears a triangle 
onto its base (Fig. 2C). 
TAD boundary: genomic interval that delimitates two neighboring TADs. 
Chromatin loop: 3D interaction between two genomic regions that are located several ki-
lobases away from each other on the same chromosome. On a high-resolution, 
triangular chromatin contact heatmap it appears as an isolated dot separated from 
the base (Fig. 2D). 
CTCF/cohesin complex: protein complex involved in the formation of some chromatin loops 
and TAD boundaries. 
LAD: megabase-sized chromosomal domain in close proximity to the nuclear lamina and 
possibly physically associated to its proteinaceous components; generally associated 
with poor transcriptional activity. 
Transcription factories: nuclear foci of RNA Pol II associated to high transcriptional activity. 
trans chromatin interaction: physical proximity between loci located on different 
chromosomes. 
eQTL: genomic locus that explains a portion of the genetic variance of a gene expression 
phenotype. 
GWAS: study that aims to identify genetic variants associated with a phenotype, often a 
disease, by mapping its segregation with many genetic markers in a population. 
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